97 related articles for article (PubMed ID: 3875662)
1. Expression of activation antigens by T cells infiltrating basal cell carcinomas.
Guillén FJ; Day CL; Murphy GF
J Invest Dermatol; 1985 Sep; 85(3):203-6. PubMed ID: 3875662
[TBL] [Abstract][Full Text] [Related]
2. Expression of human lymphocyte antigen (HLA)-DR on tumor cells in basal cell carcinoma.
Kohchiyama A; Oka D; Ueki H
J Am Acad Dermatol; 1987 Apr; 16(4):833-8. PubMed ID: 2952686
[TBL] [Abstract][Full Text] [Related]
3. Local immune response in basal cell carcinoma: characterization by transmission electron microscopy and monoclonal anti-T6 antibody.
Murphy GF; Krusinski PA; Myzak LA; Ershler WB
J Am Acad Dermatol; 1983 Apr; 8(4):477-85. PubMed ID: 6602155
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
Chaux P; Moutet M; Faivre J; Martin F; Martin M
Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
[TBL] [Abstract][Full Text] [Related]
5. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
[TBL] [Abstract][Full Text] [Related]
6. Expression of class II antigens by subsets of activated T cells.
Zier KS
Cell Immunol; 1986 Jul; 100(2):525-31. PubMed ID: 3093090
[TBL] [Abstract][Full Text] [Related]
7. Intralesional T lymphocyte phenotypes and HLA-DR expression in Melkersson-Rosenthal syndrome.
Rönnblom L; Forsum U; Evrin PE; Gillnäs T; Nethander G
Int J Oral Maxillofac Surg; 1986 Oct; 15(5):614-9. PubMed ID: 3097189
[TBL] [Abstract][Full Text] [Related]
8. Characterization of T lymphocyte and monocyte populations in HLA B8/DRw3 normal individuals and in patients with dermatitis herpetiformis.
Hall RP; Leiserson WM; Chused TM; Lawley TJ
J Invest Dermatol; 1984 Mar; 82(3):231-4. PubMed ID: 6230405
[TBL] [Abstract][Full Text] [Related]
9. T-lymphocyte subsets and HLA-DR-expressing cells in rejected human kidney grafts.
Tufveson G; Forsum U; Claesson K; Klareskog L; Larsson E; Karlsson-Parra A; Frödin L
Scand J Immunol; 1983 Jul; 18(1):37-40. PubMed ID: 6348936
[TBL] [Abstract][Full Text] [Related]
10. Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma.
Hersey P; Murray E; Grace J; McCarthy WH
Pathology; 1985 Jul; 17(3):385-91. PubMed ID: 2866482
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
Masuyama J; Minato N; Kano S
J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of class II MHC antigens on cells derived from human tissue.
McDowell B; Cifelli AT; Nunn JD; Katz DR
Adv Exp Med Biol; 1985; 186():1043-50. PubMed ID: 3876697
[TBL] [Abstract][Full Text] [Related]
13. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
14. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.
Nestle FO; Burg G; Fäh J; Wrone-Smith T; Nickoloff BJ
Am J Pathol; 1997 Feb; 150(2):641-51. PubMed ID: 9033277
[TBL] [Abstract][Full Text] [Related]
15. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.
Whitwell HL; Hughes HP; Moore M; Ahmed A
Br J Cancer; 1984 Feb; 49(2):161-72. PubMed ID: 6365133
[TBL] [Abstract][Full Text] [Related]
16. HLA expression in basal cell carcinomas.
Garcia-Plata D; Mozos E; Sierra MA; Peña J; Solana R
Invasion Metastasis; 1991; 11(3):166-73. PubMed ID: 1834604
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic markers in renal cell carcinoma.
Banner BF; Burnham JA; Bahnson RR; Ernstoff MS; Auerbach HE
Mod Pathol; 1990 Mar; 3(2):129-34. PubMed ID: 1691492
[TBL] [Abstract][Full Text] [Related]
18. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.
Buechner SA
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):731-4. PubMed ID: 1869644
[TBL] [Abstract][Full Text] [Related]
19. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
Engleman EG; Benike CJ; Grumet FC; Evans RL
J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
[TBL] [Abstract][Full Text] [Related]
20. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.
Scheynius A; Klareskog L; Forsum U
Clin Exp Immunol; 1982 Aug; 49(2):325-30. PubMed ID: 6751638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
